Cargando…
Different efficacy in the non-small cell lung cancer patient with bilateral synchronous lesions treated with neoadjuvant gefitinib therapy: a case report
Gefitinib, the first-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), has become the standard of care for the first-line of therapy for advanced non-small cell lung cancer (NSCLC) with common EGFR mutation. However, the efficacy of preoperative gefitinib therapy in p...
Autores principales: | Du, Wenxing, Zhao, Yandong, Xuan, Yunpeng, Qin, Yi, Xu, Rongjian, Halmos, Balazs, Fabian, Thomas, Jiao, Wenjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212137/ https://www.ncbi.nlm.nih.gov/pubmed/32395295 http://dx.doi.org/10.21037/jtd.2020.02.60 |
Ejemplares similares
-
The role of salvage surgery in the treatment of a gefitinib-resistant non-small cell lung cancer patient: a case report
por: Zang, Jing, et al.
Publicado: (2021) -
Synchronous duodenal neuroendocrine neoplasm and congenital factor XIII deficiency: case report and review of the literature
por: Shen, Lei, et al.
Publicado: (2022) -
Surgical resection of superior pulmonary sulcus tumor after neoadjuvant chemoradiation via the anterior transmanubrial approach: a case report
por: Bao, Feichao, et al.
Publicado: (2021) -
Rectal gastrointestinal stromal tumor with metachronous liver metastasis demonstrated no relapse after multidisciplinary team discussion and comprehensive treatment: a case report
por: Zhang, Xuan, et al.
Publicado: (2022) -
Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q
por: Song, Yang, et al.
Publicado: (2020)